Curated industry list

Overvalued Stocks in Pharmaceuticals on NYSE

Explore Overvalued Stocks in Pharmaceuticals on NYSE. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Bristol-Myers Squibb Company (BMY)
Fair Value-16.2% Downside Fair Analyst4.1% Upside Market Cap134.6 B P/E14.0x Yield4.0% HealthGreat
  NYSE Featured in Overvalued Stocks
China Pharma Holdings Inc (CPHI)
Fair Value-42.6% Downside Overvalued Market Cap47.816 M P/E-14.4x Yield0.0% HealthWeak
  NYSE Featured in Overvalued Stocks Technical Strength Leaders Under $10 per Share
Elanco Animal Health (ELAN)
Fair Value-22.0% Downside Overvalued Analyst15.5% Upside Market Cap12.786 B P/E-54.1x Yield0.0% HealthGood
  NYSE Featured in Overvalued Stocks
Rafael Holdings Inc Class B (RFL)
Fair Value-28.5% Downside Overvalued Market Cap97.24 M P/E-3.2x Yield0.0% HealthFair
  NYSE Featured in Overvalued Stocks
Alto Neuroscience Inc (ANRO)
Fair Value-25.7% Downside Overvalued Analyst27.2% Upside Market Cap1.097 B P/E-14.7x Yield0.0% HealthGood
  NYSE Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Impact Biomedical Inc (IBO)
Fair Value-42.6% Downside Overvalued Market Cap47.441 M P/E-3.6x Yield0.0% HealthWeak
  NYSE Featured in Overvalued Stocks
Nasus Pharma Ltd (NSRX)
Fair Value-21.2% Downside Overvalued Analyst492.4% Upside Market Cap40.988 M P/E-6.7x Yield0.0% HealthFair
  NYSE Featured in Overvalued Stocks
Veradermics Inc (MANE)
Fair Value-43.8% Downside Overvalued Analyst46.8% Upside Market Cap4.482 B P/E-45.4x Yield0.0% HealthGreat
  NYSE Featured in Overvalued Stocks
Explore listed stocks on NYSE with company information and fair value data.